Your browser doesn't support javascript.
loading
The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome.
Sperling, Laurence S; Mechanick, Jeffrey I; Neeland, Ian J; Herrick, Cynthia J; Després, Jean-Pierre; Ndumele, Chiadi E; Vijayaraghavan, Krishnaswami; Handelsman, Yehuda; Puckrein, Gary A; Araneta, Maria Rosario G; Blum, Quie K; Collins, Karen K; Cook, Stephen; Dhurandhar, Nikhil V; Dixon, Dave L; Egan, Brent M; Ferdinand, Daphne P; Herman, Lawrence M; Hessen, Scott E; Jacobson, Terry A; Pate, Russell R; Ratner, Robert E; Brinton, Eliot A; Forker, Alan D; Ritzenthaler, Laura L; Grundy, Scott M.
Affiliation
  • Sperling LS; Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia. Electronic address: lsperli@emory.edu.
  • Mechanick JI; Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Neeland IJ; Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Herrick CJ; Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, Missouri.
  • Després JP; Québec Heart and Lung Institute, Université Laval, Québec, Canada.
  • Ndumele CE; Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Vijayaraghavan K; Scottsdale Cardiovascular Center, Scottsdale, Arizona.
  • Handelsman Y; Metabolic Institute of America, Tarzana, California.
  • Puckrein GA; National Minority Quality Forum, Washington, DC.
  • Araneta MR; Department of Family and Preventive Medicine, University of California-San Diego, San Diego, California.
  • Blum QK; Inova Heart and Vascular Institute, Fairfax, Virginia.
  • Collins KK; Private Practice, Bemus Point, New York.
  • Cook S; Institute for Healthy Childhood Weight, American Academy of Pediatrics, Chicago, Illinois, and Department of Pediatrics, University of Rochester School of Medicine, Rochester, New York.
  • Dhurandhar NV; Department of Nutritional Sciences, Texas Tech University, Lubbock, Texas.
  • Dixon DL; Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia.
  • Egan BM; Department of Medicine, University of South Carolina School of Medicine, Greenville, South Carolina.
  • Ferdinand DP; Healthy Heart Community Prevention Project, Inc., New Orleans, Louisiana.
  • Herman LM; Department of Physician Assistant Studies, New York Institute of Technology, Old Westbury, New York.
  • Hessen SE; Cardiology Consultants of Philadelphia and Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Jacobson TA; Office of Health Promotion and Disease Prevention, Emory University School of Medicine, Atlanta, Georgia.
  • Pate RR; Department of Exercise Science, University of South Carolina, Columbia, South Carolina.
  • Ratner RE; American Diabetes Association, Alexandria, Virginia.
  • Brinton EA; Utah Foundation for Biomedical Research and Utah Lipid Center, Salt Lake City, Utah.
  • Forker AD; Department of Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
  • Ritzenthaler LL; American College of Cardiology, Washington, DC.
  • Grundy SM; Department of Clinical Nutrition, University of Texas Southwestern Medical Center, Dallas, Texas.
J Am Coll Cardiol ; 66(9): 1050-67, 2015 Sep 01.
Article in En | MEDLINE | ID: mdl-26314534
ABSTRACT
The Cardiometabolic Think Tank was convened on June 20, 2014, in Washington, DC, as a "call to action" activity focused on defining new patient care models and approaches to address contemporary issues of cardiometabolic risk and disease. Individual experts representing >20 professional organizations participated in this roundtable discussion. The Think Tank consensus was that the metabolic syndrome (MetS) is a complex pathophysiological state comprised of a cluster of clinically measured and typically unmeasured risk factors, is progressive in its course, and is associated with serious and extensive comorbidity, but tends to be clinically under-recognized. The ideal patient care model for MetS must accurately identify those at risk before MetS develops and must recognize subtypes and stages of MetS to more effectively direct prevention and therapies. This new MetS care model introduces both affirmed and emerging concepts that will require consensus development, validation, and optimization in the future.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Metabolic Syndrome / Health Promotion Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Am Coll Cardiol Year: 2015 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Metabolic Syndrome / Health Promotion Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Am Coll Cardiol Year: 2015 Document type: Article